These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 16723601

  • 21. In vitro and in vivo antibacterial activities of Q-35, a novel fluoroquinolone.
    Iwasaki H, Miyazaki S, Tsuji A, Yamaguchi K, Goto S.
    Chemotherapy; 1995; 41(2):100-12. PubMed ID: 7758353
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives.
    Bouzard D, Di Cesare P, Essiz M, Jacquet JP, Kiechel JR, Remuzon P, Weber A, Oki T, Masuyoshi M, Kessler RE.
    J Med Chem; 1990 May; 33(5):1344-52. PubMed ID: 2329555
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antibacterial activity of trovafloxacin against gram-positive blood culture isolates from nosocomial infections.
    Qadri SM, Ueno Y.
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):694-6. PubMed ID: 8894584
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1503-5. PubMed ID: 9624503
    [Abstract] [Full Text] [Related]

  • 30. Antibacterial activity of PD 131628 and proposed disc diffusion susceptibility test criteria.
    Fuchs PC, Barry AL, Pfaller MA.
    J Antimicrob Chemother; 1994 Jun; 33(6):1147-54. PubMed ID: 7928808
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pyridonecarboxylic acids as antibacterial agents. VI. Synthesis and structure-activity relationship of 7-(alkyl, cycloalkyl, and vinyl)-1-cyclopropyl-6-fluoro-4-quinolone-3-carboxylic acids.
    Todo Y, Takagi H, Iino F, Fukuoka Y, Ikeda Y, Tanaka K, Saikawa I, Narita H.
    Chem Pharm Bull (Tokyo); 1994 Oct; 42(10):2049-54. PubMed ID: 7805129
    [Abstract] [Full Text] [Related]

  • 37. Quality control limits for dilution and disk diffusion susceptibility tests of trovafloxacin against eight quality control strains.
    Fuchs PC, Barry AL, Brown SD.
    J Clin Microbiol; 1998 Feb; 36(2):585-6. PubMed ID: 9466783
    [Abstract] [Full Text] [Related]

  • 38. In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers.
    Fuchs PC, Barry AL, Brown SD.
    Antimicrob Agents Chemother; 1998 May; 42(5):1274-7. PubMed ID: 9593166
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Synthesis and antibacterial activity of new quinolones containing a 7-[3-(1-amino-1-methylethyl)-1-pyrrolidinyl] moiety. Gram-positive agents with excellent oral activity and low side-effect potential.
    Hagen SE, Domagala JM, Gracheck SJ, Sesnie JA, Stier MA, Suto MJ.
    J Med Chem; 1994 Mar 18; 37(6):733-8. PubMed ID: 8145222
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.